What of the following should NOT elicit an immune response in your own body? A) major histocompatibility complex (MHC) molecules bound to antigens B) self-antigens C) immunogens D) haptens bound with a protein carrier Which of the fo...
What of the following should NOT elicit an immune response in your own body? A) major histocompatibility complex (MHC) molecules bound to antigens B) self-antigens C) immunogens D) haptens bound with a protein carrierBaso...
The following are claimed: (A) hapten tracer complex comprising: (a) a hapten which is linked, directly or via a spacer gp., to an indicator component and (b) an antibody which can bind specifically to the indicator component and (B) test kit for carrying out immunoassays for determn. ...
These and other features and advantages of the present invention will become apparent after a review of the following detailed description of the disclosed embodiments. BRIEF DESCRIPTION OF THE FIGURES FIG. 1 shows a biosensor capable of simultaneously measuring several different analytes in a medium....
doi:US5834206 AStephan NeuenhoferReinhard KasmarkerUSUS5834206 * Dec 7, 1995 Nov 10, 1998 Behring Diagnostics Gmbh Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof...
Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(鈭 ...
OLIGOMER CARRIER MOLECULES IN WHICH MARKER GROUPS AND HAPTENS ARE SELECTIVELY INCORPORATEDThe present invention concerns novel conjugates, process for manufacturing them, and the use of such conjugates as antigens in immunological detection processes or in DNA diagnostic procedures.JOSEL HANS-PETER...
The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.DURRANT Linda Gillian...
A method of preparing a hapten of formula I Hapten suitable I for use in the production of an antibody capable of binding to at least one structural epitope of a phenethanolamine such as, but not limited to, ractopamine, isoxsuprine or ritodrine, the method comprising the step of reacting a...
The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.LINDA GILLIAN DURRANT...